Halofantrine
Therapeutic agent (verify pharmacological class)
What it is used for
Therapeutic use is agent- and indication-specific within the class (Therapeutic agent (verify pharmacological class)). Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC. Acute P. falciparum and P. vivax.
Warnings
Excreted in milk, prolonged QTC interval, not used in cerebral malaria in com-bination with other medicine or clinical conditions, which prolong QTC interval, or patient with ventricular dysrrythmias. Consider ECG to exclude above conditions. Renal and hepatic impairment, evidence of increased CNS side effects when associated with either therapeutic or prophylactic use of chloroquine or sulphadoxine / pyrimethamine.
Possible side effects
Skin rashes, pruritus, GI disturbances, severe ventricular dysrrhythmias that may be associated with death, this risk is increased by the use of high doses or concomitant or recent use of mefloquine. AV conduction disorders or unexplained syncopal attacks.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.